The Symphony of Shadows: Exploring the Mysteries That Dance in the Dark"

We are determined to communicate and cooperate with expert scientists in this field, universities, scientific and research centers, companies, and pharmaceutical factories to achieve our goals and strategies. These collaborations and the use of experiences are on the agenda, and we are interested in expanding our activities in this field.

Open Position

CanChip GmbH welcomes any kind of cooperation and research in the field of organ-on-chip (OoC) and tumor-on-chip (ToC). By creating suitable opportunities and conditions, we can and are interested in providing a platform for any type of cooperation with universities, scientific and research centers, pharmaceutical factories, associations, professors, and students.

Collaborator

We believe that consulting and using the valuable experiences of professors and experts in this field can be very helpful and inspiring for us, so we are eager to use this case with full interest. We are proud that in the field of optimal marketing and commercialization of this technique, we benefit from the expert and professional advice of Mr. Dr. Clive, and in the field of quality and technical control, we benefit from the advice and support of Fraunhofer Potsdam Company.

Clive is a founding member, and member of the Board of Directors of the 3Rs Collaborative (formerly North American 3Rs Collaborative )as well as one of the Board of Members of the UK NC3Rs. He is a European Registered Toxicologist (ERT), a charted Fellow of the Royal Society of Biology, and a member of ASCCT and ACTC. He is now the Vice President and board member of ESTIV. As of July 2023, He joined PeptiMatrix as Board Chair.
Dr Clive Roper
PhD in in vitro dermal metabolism and toxicology from Newcastle University

Collaborator

Fraunhofer Potsdam Company

Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytic and Bioprocesses IZI-BB.

The Bioanalytic and Bioprocesses Branch in Potsdam-Golm was affiliated with the Fraunhofer Institute for Cell Therapy and Immunology on July 1, 2014. The site was initially founded in 2005 as a branch of the Fraunhofer IBMT and has since worked on technological solutions for biomedicine and diagnostics as well as for biotechnology and bioproduction.

The interdisciplinary team comprising natural scientists, engineers, and technicians develops powerful, analytical methods for the detection and validation of pathogens and biological markers besides processes to obtain, handle, and manipulate cells and biomolecules. In this context, the team develops applications for personalized medicine, as well as biosensors and detection procedures for the areas of agriculture and the environment, for a broad spectrum of substance classes. The site has the state-of-the-art infrastructure required for miniaturizing and automating biological processes. This includes various biosensor and biochip technologies, pipetting robots, and micro and nano-dispensers, besides many different rapid-prototyping procedures. A further special feature of the branch‘s facilities is the life culture collection of cryophilic algae (CCCryo), which serves as a resource for developing production processes for a novel, industrial bioproducts.